$171 Million is the total value of Anson Funds Management LP's 26 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 92.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRcall | $68,091,000 | -14.0% | 251,000 | -16.6% | 39.91% | -32.4% |
| NVDA | New | NVIDIA CORPput | $29,684,000 | – | 125,300 | +100.0% | 17.40% | – |
| AMZN | New | AMAZON COM INCput | $20,398,000 | – | 12,000 | +100.0% | 11.96% | – |
| UBNT | New | UBIQUITI NETWORKS INCput | $12,200,000 | – | 144,000 | +100.0% | 7.15% | – |
| GG | New | GOLDCORP INC NEW | $6,678,000 | – | 392,125 | +100.0% | 3.91% | – |
| DXJ | WISDOMTREE TRjapn hedge eqt | $4,642,000 | -3.6% | 86,000 | 0.0% | 2.72% | -24.2% | |
| AMRWW | Buy | ALTA MESA RES INC*w exp 03/28/202 | $4,236,000 | +1.4% | 622,006 | +19.2% | 2.48% | -20.2% |
| AMRQQ | Buy | ALTA MESA RES INCcl a | $3,916,000 | +18.6% | 575,000 | +39.4% | 2.30% | -6.7% |
| GOLD | RANDGOLD RES LTDadr | $3,855,000 | -7.4% | 50,000 | 0.0% | 2.26% | -27.2% | |
| TAC | New | TRANSALTA CORP | $3,465,000 | – | 525,000 | +100.0% | 2.03% | – |
| MSFT | Sell | MICROSOFT CORP | $2,958,000 | -45.8% | 30,000 | -49.8% | 1.73% | -57.4% |
| EYESW | Sell | SECOND SIGHT MED PRODS INC*w exp 03/06/202 | $2,217,000 | -13.7% | 1,335,561 | -0.2% | 1.30% | -32.1% |
| STKS | Sell | THE ONE GROUP HOSPITALITY IN | $2,013,000 | -39.7% | 828,551 | -31.7% | 1.18% | -52.6% |
| CEF | New | SPROTT PHYSICAL GOLD & SILVEtr unit | $1,504,000 | – | 120,000 | +100.0% | 0.88% | – |
| SMSI | Sell | SMITH MICRO SOFTWARE INC | $1,308,000 | +23.0% | 571,312 | -20.0% | 0.77% | -3.2% |
| SHIPW | SEANERGY MARITIME HLDGS CORP*w exp 11/10/202 | $1,239,000 | -0.9% | 1,432,500 | 0.0% | 0.73% | -22.1% | |
| ACST | New | ACASTI PHARMA INCcl a new | $527,000 | – | 684,600 | +100.0% | 0.31% | – |
| RXIIW | Sell | RXI PHARMACEUTICALS CORP NEW*w exp 12/16/202 | $421,000 | -41.1% | 218,023 | -1.9% | 0.25% | -53.7% |
| GNUS | Sell | GENIUS BRANDS INTL INC | $405,000 | -71.1% | 200,000 | -62.3% | 0.24% | -77.3% |
| CVM | New | CEL SCI CORP | $310,000 | – | 336,500 | +100.0% | 0.18% | – |
| ATOS | New | ATOSSA GENETICS INC | $240,000 | – | 108,977 | +100.0% | 0.14% | – |
| NVIV | New | INVIVO THERAPEUTICS HLDGS CO | $93,000 | – | 54,450 | +100.0% | 0.06% | – |
| NSPR | New | INSPIREMD INC | $92,000 | – | 369,774 | +100.0% | 0.05% | – |
| NSPRZ | INSPIREMD INC*w exp 03/14/202 | $62,000 | -76.2% | 250,000 | 0.0% | 0.04% | -81.4% | |
| IMUCW | Sell | IMMUNOCELLULAR THERAPEUTICS*w exp 08/12/202 | $30,000 | +3.4% | 117,187 | -0.0% | 0.02% | -18.2% |
| INPX | New | INPIXON | $29,000 | – | 181,624 | +100.0% | 0.02% | – |
| Exit | INTEC PHARMA LTD JERUSALEM | $0 | – | -50,000 | -100.0% | -0.24% | – | |
| ROKU | Exit | ROKU INC | $0 | – | -30,000 | -100.0% | -0.70% | – |
| IMAX | Exit | IMAX CORP | $0 | – | -50,000 | -100.0% | -0.72% | – |
| LFIN | Exit | LONGFIN CORPput | $0 | – | -60,000 | -100.0% | -0.77% | – |
| IPCI | Exit | INTELLIPHARMACEUTICS INTL IN | $0 | – | -2,128,720 | -100.0% | -0.90% | – |
| SHOP | Exit | SHOPIFY INCcl a | $0 | – | -7,500 | -100.0% | -0.99% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -4,113,892 | -100.0% | -1.12% | – |
| CEF | Exit | CENTRAL FD CDA LTDcl a | $0 | – | -120,000 | -100.0% | -1.18% | – |
| CANF | Exit | CAN-FITE BIOPHARMA LTDsponsored adr | $0 | – | -1,357,586 | -100.0% | -1.46% | – |
| SJR | Exit | SHAW COMMUNICATIONS INCcl b conv | $0 | – | -200,000 | -100.0% | -3.70% | – |
| HDS | Exit | HD SUPPLY HLDGS INC | $0 | – | -392,125 | -100.0% | -4.93% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.